New non-invasive MRI biomarker for liver disease could cut costs for drug trials
Oxford September 22nd, 2020. Latest research from Perspectum shows how a new non-invasive combined imaging and blood biomarker could accurately identify NASH i…
22 Sep 2020
How to Choose an Imaging Provider for Your Clinical Trial
Medical Imaging plays an important role in the clinical development of new drugs. In non-alcoholic steatohepatitis (NASH) specifically, it is one of the most c…
22 Sep 2020
Beyond the Biopsy
Perspectum is a proud sponsor and supporter of the Global Liver Institute's Beyond the Biopsy initiative and its mission to accelerate the acceptance and adopt…
8 Sep 2020
Perspectum Partners with UT Southwestern Medical Center on Dallas Heart & Minds Study
Dallas, Texas, August 18, 2020 - Perspectum® is proud to announce a collaboration with UT Southwestern Medical Center, to include LiverMultiScan® technology …
18 Aug 2020
Multiparametric MRI: bridging the diagnostic gap for liver disease
Oxford, August 7th, 2020. A review of techniques for clinical decision making in diffuse liver disease, published this week in Abdominal Radiology, highlights …
7 Aug 2020
Meet the team: Improving Outcomes through Customer Success
Our mission is to improve the lives of patients. We do this by building best-in-class technologies and working collaboratively with our customers to bring thos…
6 Aug 2020
Quantitative MRI; a game changer for identifying the chronic liver disease patients most at risk of poor clinical outcomes
Oxford, August 6th, 2020. Perspectum’s cT1® is the best non-invasive predictor of clinical outcomes in chronic liver disease (CLD) patients, new research pu…
4 Aug 2020
The link between type 2 diabetes and liver disease: can screening for NAFLD reduce liver-related mortality?
Oxford, July 23, 2020. A review of screening modalities and treatment options for individuals with type 2 diabetes and non-alcoholic fatty liver disease (NAFLD…
23 Jul 2020
Perspectum expands AI and imaging CRO portfolio with Cardiac Imaging
San Francisco, Oxford, July 15, 2020. Perspectum, a leading medical imaging company, has begun work on expanding its offering by including cardiac and lung ima…
16 Jul 2020
Perspectum Launches Multi-Site NASH Study to Accelerate Patient Enrollment
Dallas, Texas, July 7, 2020 – Perspectum is collaborating with top medical institutions to evaluate the diagnostic performance of their flagship product, Liv…
7 Jul 2020
Perspectum partners in a multimillion pound research project (ID-LIVER) to help prevent patients from developing liver cancer
Oxford, England, 3rd July 2020 Perspectum are proud to announce a new partnership to improve the lives of patients with liver disease by providing earlier and …
3 Jul 2020
High liver fat associated with a higher risk for severe COVID-19
Oxford, Jun 21, 2020. High liver fat is associated with a higher risk of developing more severe COVID-19 infection, new research finds. Scientists from Pers…
21 Jun 2020